Genmab — Maj 2014
-
genmab elsker at lave aftennews
-
Ihvertfald underligt at tage både gazyva og arzerra op og så udskyde begge. Herudover har begge jo hunget siden sommer/efteråret 2013, så de trænger også til en afklaring
-
Recommended
-
Page or document not found | European Medicines Agency (EMA)
We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.
European Medicines Agency (EMA) (www.ema.europa.eu)
-
Gazyva får også thumbs up
-
Det er så vigtigt at Arzerra
får bendamustine med på label! -
Gazyvaro, hvad fanden er det for et navn.
-
Nej. de bruger det også i USA. Det er godkendt som mono-terapi, men ikke tidligere i kombi med cd20 antistof. Så vidt jeg ved er det brugt en del i kombi med rituximab off-label
anbefaler udvidet brug af ArzerraHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind